Clinical Trials on Physicians, Primary Care in Netherlands

Total 5865 results

University Medical Center Groningen

Enrolling by invitation

Effects of Communication Training to Involve Older People in Decisions to DEPRESCRIBE Cardiometabolic Medication: a Cluster-randomized Trial in Primary Care (CO-DEPRESCRIBE)

Primary Health Care | Polypharmacy | Deprescriptions | Community Pharmacy Services | Decision Making, Shared

Netherlands
Dicerna Pharmaceuticals, Inc.

Terminated

A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)

Primary Hyperoxaluria Type 1

Netherlands, Germany
SIR Institute for Pharmacy Practice and Policy

Recruiting

Optimising Medication With Focus on Deprescribing in Frail Older People With Multidose Drug Dispensing Systems

Primary Health Care | Polypharmacy | Deprescriptions | Community Pharmacy Services

Netherlands
Radboud University Medical Center
Stichting Kwaliteit en Ontwikkeling Huisartsenzorg; Centrale Huisartsenpost...

Completed

The Effect of Substitution of Out-of-hours Care From General Practitioners to Nurse Practitioners

Out-of-hours Care Services | Primary Healthcare

Netherlands
Radboud University Medical Center

Completed

Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment (PAGODE)

Primary Aldosteronism | Primary Hyperaldosteronism

Netherlands
Radboud University Medical Center
Stichting Kwaliteit en Ontwikkeling Huisartsenzorg; GP Cooperative Emmen (CHD...

Completed

The (Cost-)Effectiveness of Physician Assistants Working at the Primary Out of Hours Emergency Service

Primary Healthcare | Out-of-hours Medical Care

Netherlands
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

The (Cost-)Effectiveness of Nurse Practitioners Working at the Primary Out of Hours Emergency Service

Primary Health Care | Out of Hours Medical Care

Netherlands
Radboud University Medical Center

Completed

Nijmegen Antihypertensive Management Improvement Study (NAMIS)

Primary Hypertension

Netherlands
Radboud University Medical Center
Terumo Medical Corporation

Completed

Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT (CONTROL)

Primary Liver Cancer | Liver Cancer | Liver Metastasis Colon Cancer

Netherlands
UMC Utrecht

Completed

Early Detection of Primary Antibody Deficiencies in Primary Care Facilities by an Algorithm Driven Selection of Serologic Testing in Individuals at Risk. (GP-PAD II)

Primary Antibody Deficiencies

Netherlands
OxThera

Completed

Phase 2/3 Oxabact Study

Primary Hyperoxaluria

United States, Germany, Netherlands
Taris Biomedical LLC

Completed

Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer

Urinary Bladder Cancer

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Confocal Laser Endomicroscopy in the Lower Urinary Tract

Urothelial Carcinoma | Bladder Neoplasm

Netherlands
Radboud University Medical Center
Terumo Medical Corporation

Enrolling by invitation

MRI-guided Holmium-166 Radioembolization (EMERITUS-2)

Primary Liver Cancer | Non-Resectable Hepatocellular Carcinoma

Netherlands
Xenon Pharmaceuticals Inc.

Completed

Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)

Inherited Erythromelalgia | Primary Erythromelalgia

Netherlands
Maastricht University Medical Center

Completed

Effect of Pulse Rate Changes on Clinical Outcome

Overactive Bladder Syndrome | Chronic Urinary Retention

Netherlands
Neuspera Medical, Inc.

Completed

Acute Study to Evaluate a Novel Implantable Midfield Powered Device in Humans With Urinary Incontinence

Overactive Bladder

Netherlands
UMC Utrecht
Erasmus Medical Center; Amsterdam UMC, location VUmc

Completed

Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile (POPCORn)

Cardiovascular Diseases

Netherlands
Alnylam Pharmaceuticals

Completed

Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1

Primary Hyperoxaluria Type 1 (PH1)

France, United Kingdom, Netherlands, Israel, Germany
Heleen Grootjans
Chiesi Farmaceutici S.p.A.

Recruiting

Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients (REVOLUTION)

Lung Transplant; Complications

Netherlands
UMC Utrecht

Unknown

Probiotics in Patients With Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis

Netherlands
Dicerna Pharmaceuticals, Inc.

Completed

Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients (PHYOX4)

Primary Hyperoxaluria Type 3

United States, Germany, Netherlands, United Kingdom
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Active, not recruiting

SIGHT Study: Cost-effectiveness of InnFocus Microshunt Implantation vs. Trabeculectomy. (SIGHT)

Primary Open-angle Glaucoma

Netherlands
Maastricht University Medical Center

Completed

Pregnancy Chances in Classic Galactosemia

Primary Ovarian Insufficiency | Galactosemias

Netherlands
Maastricht University

Active, not recruiting

Healthy Childcare Centre of the Future (HCCF)

Health and Wellbeing of Primary School-aged Children

Netherlands
Maastricht University Medical Center
The Dutch Galactosemia Society

Unknown

Inactive FSH in Galactosemia

Galactosemia | Premature Ovarian Failure

Netherlands
University Medical Center Groningen
Amsterdam UMC, location VUmc

Completed

Ventricular Reversed Remodeling After LTX in PAH Patients (PAH-LTX)

Pulmonary Arterial Hypertension

Netherlands
Dicerna Pharmaceuticals, Inc.

Completed

Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria

Primary Hyperoxaluria

United States, France, Germany, Netherlands, United Kingdom
University Medical Center Groningen
Genzyme, a Sanofi Company

Completed

Safety and Imaging Study of GC1008 in Glioma

Primary Brain Tumors

Netherlands
Bayer

Completed

A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)

Overactive Bladder | Diabetic Neuropathic Pain | Endometriosis Related Pain | Refractory or Unexplained Chronic Cough

Netherlands
Leiden University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

Repeated GON Injections in CCH (REGON)

Cluster Headache

Netherlands
The Netherlands Cancer Institute

Recruiting

The Prospective Observational COMPRAYA Cohort Study (COMPRAYA)

Cancer | Fertility Issues | Genetic Disease | Lifestyle | Survivorship | Distress, Emotional | Second Cancer

Netherlands
UMC Utrecht
Netherlands Brain Foundation

Recruiting

Treatment of Ectopic Calcification in Fahr's Disease or Syndrome (CALCIFADE)

Fahr Disease | Fahr Syndrome | Primary Familial Brain Calcification

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Effect of a SI-MMC on the IVR Rate After Ureteroscopy for UTUC (SINCERE)

Upper Urinary Tract Carcinoma

Netherlands
Amsterdam UMC, location VUmc

Unknown

Goal Oriented Strategy to Preserve Ejection Fraction Trial (GOSPEL)

Pulmonary Arterial Hypertension

Netherlands
Erasmus Medical Center
Merck Sharp & Dohme LLC

Active, not recruiting

Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab (RESPONDER)

Biomarkers | Transitional Cell Carcinoma of the Bladder

Netherlands
Boehringer Ingelheim

Completed

Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.

Renal Insufficiency, Chronic

Netherlands
Academisch Ziekenhuis Maastricht

Unknown

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

Carcinoma of Unknown Primary

Netherlands
Radboud University Medical Center
Dutch Cancer Society

Recruiting

Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients (INTRO)

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

Netherlands
University Medical Center Groningen

Completed

Simple Intensive Care Studies II (SICS-II)

Critical Illness

Netherlands
Radboud University Medical Center
Alzheimer's Association; VCVGZ Fund;; Dutch Occupational Therapy Association

Unknown

Effects of Community Occupational Therapy in Older Patients With Dementia and Their Caregivers.

Community Occupational Therapy | Dementia Patients | Primary Caregivers of Dementia Patients

Netherlands
University Medical Center Groningen

Recruiting

Investigating Cardiovascular Adverse Events Related to Cancer Treatment (InvestiCAT)

Toxicity Due to Chemotherapy | Cancer, Treatment-Related | Cardiovascular Morbidity

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma

Urothelial Carcinoma | Ureter Cancer | Urinary Tract Cancer

Netherlands
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Stichting... and other collaborators

Recruiting

Generation R Next - Optimaal Opgroeien

Pregnancy Complications | Pregnancy Outcome | Risk Reduction Behavior | Pregnancy Early | Lifestyle Factors | Preconception Care | Outcome, Adverse Birth

Netherlands
Eli Lilly and Company

Completed

Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance

Chronic Kidney Disease

Netherlands
European Organisation for Research and Treatment...

Terminated

Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer

Bladder Cancer

France, Netherlands
Radboud University Medical Center

Recruiting

Multi-Omics to Predict the Blood Pressure Response to Antihypertensives (HT-PREDICT)

Primary Hypertension

Netherlands
Bayer

Completed

A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the Vein

Biological Availability

Netherlands
Radboud University Medical Center

Completed

Exercise Induced Improvement of the Venous Reserve Capacity in Formerly Pre-eclamptic Women

Preeclampsia

Netherlands
Radboud University Medical Center

Unknown

Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia

Preeclampsia

Netherlands

Clinical Trials on Physicians, Primary Care in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations